SPY314.38-1.80 -0.57%
DIA257.24-3.48 -1.33%
IXIC10,547.75+55.25 0.53%

Northland Capital Markets Initiates Coverage On Verrica Pharmaceuticals with Outperform Rating, Announces Price Target of $21

Northland Capital Markets analyst Tim Chiang initiates coverage on Verrica Pharmaceuticals (NASDAQ:VRCA) with a Outperform rating and announces Price Target of $21.

Benzinga · -
Northland Capital Markets analyst Tim Chiang initiates coverage on Verrica Pharmaceuticals (NASDAQ: VRCA) with a Outperform rating and announces Price Target of $21.